No article notes available at this time.
• Provides a population-level estimate of RIS risk stratified by primary tumor site, giving orthopedic and oncologic surgeons a data-driven reference point when a mass develops in a previously irradiated field. • Supports a modestly elevated but statistically significant risk of RIS specifically after breast cancer radiotherapy compared to other cancers, which is relevant when counseling patients or maintaining a high index of suspicion for secondary sarcoma in long-term survivors. • As a large registry-based analysis, it adds epidemiologic context to RIS risk rather than changing acute management, and should be interpreted as one data point within the broader literature on secondary malignancies after radiotherapy.
No article notes available at this time.
• Provides a population-level estimate of RIS risk stratified by primary tumor site, giving orthopedic and oncologic surgeons a data-driven reference point when a mass develops in a previously irradiated field. • Supports a modestly elevated but statistically significant risk of RIS specifically after breast cancer radiotherapy compared to other cancers, which is relevant when counseling patients or maintaining a high index of suspicion for secondary sarcoma in long-term survivors. • As a large registry-based analysis, it adds epidemiologic context to RIS risk rather than changing acute management, and should be interpreted as one data point within the broader literature on secondary malignancies after radiotherapy.